Table 2 Comparison of baseline data between patients with and without 3-month PSD

Demographic characteristics,

 Age, year

68.1 ± 10.8

66.0 ± 11.5

 Male, %

42 (46.2)

126 (53.6)

 Education < 12 years, %

59 (64.8)

113 (48.1)

Risk factors, %

 Hypertension

69 (75.8)

171 (72.8)

 Diabetes mellitus

40 (44.0)

43 (18.3)

 Hyperlipidemia

14 (15.4)

55 (23.4)

 Coronary heart disease

16 (17.6)

30 (12.8)

 Current smoking

34 (37.4)

103 (43.8)

Clinical data

 Systolic blood pressure, mmHg

136.9 ± 24.9

136.0 ± 17.4

 Diastolic blood pressure, mmHg

82.4 ± 9.5

82.0 ± 10.1

 Body mass index, kg/m²

24.6 ± 2.7

24.2 ± 2.4

 Baseline NIHSS, score

5.0 (3.0, 8.0)

5.0 (2.0, 8.0)

 Advanced liver fibrosis, %

32 (35.2)

48 (20.4)

 FIB-4 index

2.3 (1.3, 3.1)

1.8 (1.3, 2.5)

 Stroke subtypes, %

 Large artery atherosclerosis

42 (46.2)

107 (45.5)

 Cardioembolism

20 (22.0)

43 (18.3)

 Small vessel occlusion

20 (22.0)

71 (30.2)

Others

9 (9.9)

14 (6.0)

Side of infarction, %

 Left

46 (50.5)

119 (50.6)

 Right

53 (58.2)

128 (54.5)

Laboratory data

 Platelet, 10⁹/L

177.5 ± 60.2

186.2 ± 57.4

 Aspartate transaminase, U/L

31.8 ± 24.2

28.2 ± 16.9

 Alanine transaminase, U/L

34.0 ± 21.3

32.0 ± 20.0

 Total cholesterol, mmol/L

4.0 ± 1.1

4.0 ± 1.1

 Triglyceride, mmol/L

1.4 (1.1, 1.8)

1.3 (1.0, 1.8)

 High-density lipoprotein, mmol/L

1.0 ± 0.2

1.0 ± 0.2

 Low-density lipoprotein, mmol/L

2.5 (1.9, 3.0)

2.3 (1.8, 2.9)

 Blood glucose, mmol/L

5.3 ± 1.7

5.4 ± 1.6

 Hs-CRP, mg/L

5.6 (2.0, 7.0)

4.0 (1.0, 6.0)